At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes.

Abstract:

:The newer, atypical antipsychotic drugs have improved the treatment of schizophrenia and are widely used. A disadvantage is that they increase food intake, promote weight gain and may facilitate development of diabetes. The mechanism of the latter effect is controversial. A possible interaction of these drugs with glucose transporters has been proposed: peripheral insulin resistance may develop if these drugs inhibited glucose transport in cells which express the insulin responsive glucose transporter, GLUT4, i.e., muscle and adipocytes. To test this hypothesis, we incubated 3T3-L1 adipocytes, which express GLUT1 and GLUT4, with the atypical antipsychotic drug olanzapine for 1 or 20 h and then measured basal and insulin-stimulated glucose transport. The doses of olanzapine tested (70 nM and 350 nM) encompass and exceed maximal steady-state concentrations of the drug in plasma of patients maintained on maximal recommended doses (20 mg QD) of olanzapine. A maximally stimulating insulin concentration (100 nM) accelerated glucose transport 10- to 15-fold in 3T3-L1 adipocytes, and the half-maximally stimulating insulin dose was 0.4 nM. Olanzapine (70 or 350 nM) did not affect basal or insulin-stimulated glucose transport following 1 or 20 h drug treatment at any insulin concentration tested. The data do not support the hypothesis that olanzapine at therapeutically relevant concentrations may cause peripheral insulin resistance by direct interaction with the insulin responsive glucose transport system.

authors

Robinson KA,Yacoub Wasef SZ,Buse MG

doi

10.1016/j.pnpbp.2005.06.008

subject

Has Abstract

pub_date

2006-01-01 00:00:00

pages

93-8

issue

1

eissn

0278-5846

issn

1878-4216

pii

S0278-5846(05)00201-0

journal_volume

30

pub_type

杂志文章
  • More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia.

    abstract::Enhancement of neurocognition is essential in the treatment of schizophrenia. In our previously reported six-week randomized controlled trial (RCT) mirtazapine added to conventional antipsychotics improved not only negative, but also positive symptoms and neurocognition in difficult-to-treat schizophrenia. The present...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.pnpbp.2011.03.004

    authors: Stenberg JH,Terevnikov V,Joffe M,Tiihonen J,Tchoukhine E,Burkin M,Joffe G

    更新日期:2011-06-01 00:00:00

  • Antipsychotics and single-cell activity in the rat superior colliculus.

    abstract::Schizophrenic patients have problems with saccadic eye movements that can be characterized as a loss of control over the saccadic system. Preliminary clinical results suggest that antipsychotics can either disrupt or improve saccadic performance. The brain mechanism through which antipsychotics might affect saccades i...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(01)00276-7

    authors: Broerse A,Timmerman W,Westerink BH,Den Boer JA

    更新日期:2002-02-01 00:00:00

  • Disrupted regional homogeneity in treatment-resistant depression: a resting-state fMRI study.

    abstract:BACKGROUND:Using a newly developed regional homogeneity (ReHo) approach, we were to explore the features of brain activity in patients with treatment-resistant depression (TRD) in resting state, and further to examine the relationship between abnormal brain activity in TRD patients and specific symptom factors derived ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2011.02.006

    authors: Guo WB,Sun XL,Liu L,Xu Q,Wu RR,Liu ZN,Tan CL,Chen HF,Zhao JP

    更新日期:2011-07-01 00:00:00

  • Understanding facial expressivity in autism spectrum disorder: An inside out review of the biological basis and clinical implications.

    abstract::Deficits in decoding and understanding facially expressed emotions occur commonly in persons with autism spectrum disorder (ASD), which contribute to the impairment of social communication that serves as one of its core diagnostic criteria. Research suggests that abnormalities of visual scanning of the face, activatio...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2018.05.009

    authors: Deutsch SI,Raffaele CT

    更新日期:2019-01-10 00:00:00

  • Effects of lithium carbonate on reproductive hormones in healthy men: relationship with body weight regulation--a pilot study.

    abstract::1. To test the hypothesis that lithium-induced body weight gain is related to an unbalance in the reproductive hormones, lithium carbonate (900 mg/day) or placebo was administered to healthy men for 1 month. 2. Body weight, skin folds and the serum levels of thyrotropic hormone, tetraiodothyroxine, prolactin, follicle...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0278-5846(97)00090-0

    authors: Baptista T,Alastre T,Contreras Q,Martinez JL,Araujo de Baptista E,Burguera JL,de Burguera M,Hernández L

    更新日期:1997-08-01 00:00:00

  • Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia.

    abstract:OBJECTIVE:To investigate (i) the association between four serotonergic polymorphisms (A-1438G and T102C of the 5-HT2A receptor gene, and 5-HTT VNTR and 5-HTTLPR of the 5-HT transporter gene) and schizophrenia and (ii) the potential interaction of those polymorphisms in the development of schizophrenia. SUBJECTS AND ME...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2007.01.012

    authors: Sáiz PA,García-Portilla MP,Arango C,Morales B,Alvarez V,Coto E,Fernández JM,Bascarán MT,Bousoño M,Bobes J

    更新日期:2007-04-13 00:00:00

  • Psychological traits and platelet monoamine oxidase activity in eating disorder patients: their relationship and stability.

    abstract::Self-reported behavior and attitudes towards eating [Eating Disorder Inventory-2; Garner DM (1991). Eating Disorder Inventory-2: Professional Manual. Odessa, Fl.: Psychological Assessment Resources; Estonian version Podar I, Hannus A, Allik J (1999). Personality and Affectivity Characteristics Associated With Eating D...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2006.06.025

    authors: Podar I,Jaanisk M,Allik J,Harro J

    更新日期:2007-01-30 00:00:00

  • Sputum interleukin-6, tumor necrosis factor-α and Salivary cortisol as new biomarkers of depression in lung cancer patients.

    abstract::Depression is common among lung cancer patients. Increasing evidence has suggested that hypothalamic-pituitary-adrenal (HPA) axis and pro-inflammatory cytokines may play a key role in the pathophysiology of depression as well as cancer. This pilot study investigated the efficacy of sputum interleukin (IL)-6, tumor nec...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2013.08.004

    authors: Du YJ,Zhang HY,Li B,Wu X,Lv YB,Jin HL,Cao YX,Sun J,Luo QL,Gong WY,Liu BJ,Wu JF,Shi SX,Dong JC

    更新日期:2013-12-02 00:00:00

  • The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression.

    abstract::Recent brain imaging studies have shed light on understanding the pathogenesis of mood disorders. Evidence of structural, chemical, and functional brain changes, particularly in prefrontal cortex, cingulate, and amygdala, has been revealed in major depressive disorder (MDD). Furthermore, imaging techniques have been a...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2010.11.040

    authors: Bellani M,Dusi N,Yeh PH,Soares JC,Brambilla P

    更新日期:2011-08-15 00:00:00

  • Normal phospholipid-related signal transduction in autism.

    abstract::The aim of this study was to test the hypothesis that autism (a neurodevelopmental disorder of unknown etiology) is associated with altered phospholipid-related signal transduction using the niacin skin flush test. This is the first reported use of this test in this disorder. The response to topical aqueous methyl nic...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(02)00303-2

    authors: Puri BK,Singh I

    更新日期:2002-12-01 00:00:00

  • Right prefrontal function and coping strategies in patients with remitted major depressive disorder.

    abstract:BACKGROUND:Patients with remitted major depressive disorder (rMDD) generally rely on maladaptive coping strategies for stressful situations. These maladaptive copings are associated with an elevated relapse risk of rMDD; however, their neural basis remains poorly understood. METHODS:We enrolled (1) 45 patients with rM...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2020.110085

    authors: Tsujii N,Mikawa W,Adachi T,Sakanaka S,Shirakawa O

    更新日期:2020-09-02 00:00:00

  • Effects of olanzapine on aggressiveness in heroin dependent patients.

    abstract::This study compared the anti-aggressiveness effects of the atypical anti-psychotic olanzapine with that of selective serotonin reuptake inhibitors (SSRI) and benzodiazepines (BZD) among patients with heroin dependence submitted to opioid-agonists substitution treatment. Sixty-seven (67) patients who met the DSM-IV cri...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.pnpbp.2006.04.023

    authors: Gerra G,Di Petta G,D'Amore A,Iannotta P,Bardicchia F,Falorni F,Coacci A,Strepparola G,Campione G,Lucchini A,Vedda G,Serio G,Manzato E,Antonioni M,Bertacca S,Moi G,Zaimovic A

    更新日期:2006-09-30 00:00:00

  • Prospective strategies for cholinergic interventions in Alzheimer's disease.

    abstract::The cholinergic hypothesis of memory dysfunction has guided most of the recent proposals for treating the primary symptoms of AD. The efficacy of these treatments has been severely limited. This review examines two major lines of evidence which suggest that the cholinergic hypothesis may have to be expanded and revise...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/0278-5846(86)90025-4

    authors: Pomara N,Bagne CA,Stanley M,Yarbrough GG

    更新日期:1986-01-01 00:00:00

  • Adrafinil: effects on behavior and cognition in aged canines.

    abstract::1. Adrafmil is a novel vigilance promoting agent developed in France by Louis Lafon Laboratories. 2. Adrafinil causes increased locomotion without producing stereotypical activity in canines tested in an open field. 3. The effectiveness of a single treatment is long-lasting, and the effectiveness persists over repeate...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(00)00103-2

    authors: Siwak CT,Callahan H,Milgram NW

    更新日期:2000-07-01 00:00:00

  • The lithium ratio and the incidence of side effects.

    abstract::1. During a prospective and outpatient study the correlation between the lithium ratio and the incidence of lithium side effects and type of comedications was studied in 51 Iranian bipolar patients by using new direct method of measuring erythrocyte lithium concentration. 2. Results revealed that patients who received...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(98)00058-x

    authors: Dehpour AR,Emamian ES,Ahmadi-Abhari SA,Azizabadi-Farahani M

    更新日期:1998-08-01 00:00:00

  • The mouse light-dark paradigm: a review.

    abstract::1. The light/dark paradigm is based on the innate aversion of rodents to brightly illuminated areas and on the spontaneous exploratory behaviour of the animals, applying mild stressors i.e. novel environment and light. The test apparatus consists of a small dark secure compartment (one third) and a large illuminated a...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/s0278-5846(00)00151-2

    authors: Hascoët M,Bourin M,Nic Dhonnchadha BA

    更新日期:2001-01-01 00:00:00

  • Cumulative mean change procedure: application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression.

    abstract::1. A simple summary measure--namely, cumulative mean change (CMC)--is proposed for analyzing incomplete repeated measures in clinical settings. 2. A simple test statistic that uses the correlation between subject responses was derived and applied to a study comparing an investigational antidepressant, venlafaxine, wit...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0278-5846(94)90077-9

    authors: Entsuah AR,Bradley MM,Littman GS

    更新日期:1994-07-01 00:00:00

  • Noradrenergic facilitation of shock-probe defensive burying in lateral septum of rats, and modulation by chronic treatment with desipramine.

    abstract::We have previously shown that acute stress-induced release of norepinephrine (NE) facilitates anxiety-like behavioral responses to stress, such as reduction in open-arm exploration on the elevated-plus maze and in social behavior on the social interaction test. Since these responses represent inhibition of ongoing beh...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2006.11.015

    authors: Bondi CO,Barrera G,Lapiz MD,Bedard T,Mahan A,Morilak DA

    更新日期:2007-03-30 00:00:00

  • Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients.

    abstract:OBJECTIVES:Several studies have suggested insulin resistance related to dyslipidemia and body weight in drug treated schizophrenia patients. Although, insulin resistance or impaired glucose tolerance is also reported in antipsychotic naïve schizophrenia patients, their relationship with dyslipidemic changes and body we...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2010.06.011

    authors: Dasgupta A,Singh OP,Rout JK,Saha T,Mandal S

    更新日期:2010-10-01 00:00:00

  • The effects of the nitric oxide synthase inhibitors on the behaviour of small-platform-stressed mice in the plus-maze test.

    abstract::Effects of the nitric oxide synthase (NOS) inhibitors 7-nitroindazole (7-NI), N(G)-nitro-L-arginine (L-NOARG) and N(G)-nitro-L-arginine methyl ester (L-NAME) on the behaviour of control and small-platform (SP)-stressed mice in the plus-maze test were studied. SP stress was induced by placing mice on SPs (3.5 cm diamet...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(01)00261-5

    authors: Pokk P,Väli M

    更新日期:2002-02-01 00:00:00

  • Perospirone in treatment of Huntington's disease: a first case report.

    abstract::Huntington's disease (HD) is a hereditary disorder clinically characterized by involuntary movements, cognitive decline and psychiatric symptoms. We report on a patient with HD, whose involuntary movements and psychiatric symptoms were clinically improved with perospirone, a second-generation antipsychotic agent with ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2006.06.021

    authors: Roppongi T,Togo T,Nakamura S,Asami T,Yoshimi A,Shiozaki K,Kato D,Kawanishi C,Hirayasu Y

    更新日期:2007-01-30 00:00:00

  • Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics.

    abstract::1. Type I risk factor for tardive dyskinesia is defined as a risk leading primarily to a reversible form, while Type II factors to irreversible forms. 2. Central anticholinergic drugs appear as the prototype of Type I drug factor which increased the clinical manifestations of the disorder, but not its overall incidenc...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(82)80151-6

    authors: Chouinard G,Steinberg S

    更新日期:1982-01-01 00:00:00

  • Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study.

    abstract::Five schizophrenic patients (diagnosed using Research Diagnostic Criteria) under treatment with intramuscular fluphenazine decanoate or oral fluphenazine dihydrochloride had serial plasma fluphenazine and plasma prolactin levels determined by a direct radioimmunoassay method. Clinical state was assessed utilizing the ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/0278-5846(83)90068-4

    authors: Dudley J,Rauw G,Hawes EM,Keegan DL,Midha KK

    更新日期:1983-01-01 00:00:00

  • Estradiol, TRH and striatal dopaminergic mechanisms.

    abstract::1. Estrogens have been shown to decrease the effect of apomorphine in a variety of animal behavioral models reflecting the sensitivity of striatal and mesolimbic dopamine receptors. 2. These include circling, and locomotor activity, in rats and suppression of midbrain tremor as well as lingual dyskinesia in monkeys. 3...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/s0278-5846(82)80149-8

    authors: Bédard PJ,Malouin F,Dipaolo T,Labrie F

    更新日期:1982-01-01 00:00:00

  • Effect of Yi-Gan San on psychiatric symptoms and sleep structure at patients with behavioral and psychological symptoms of dementia.

    abstract:OBJECTIVE:Recently, traditional herbal medicines have been reported to be effective for behavioral and psychological symptoms of dementia (BPSD). This study aims to examine the efficacy of Yi-Gan San (YGS) in the improvement of BPSD and sleep disorders in patients with dementia. METHODS:Five patients (1 male and 4 fem...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.pnpbp.2007.12.027

    authors: Shinno H,Inami Y,Inagaki T,Nakamura Y,Horiguchi J

    更新日期:2008-04-01 00:00:00

  • Differences between self-reported and clinician-rated evaluations of 1-year changes in auditory verbal hallucinations among schizophrenia patients.

    abstract::Auditory verbal hallucinations (AVHs) constitute a frequent and distressing symptom of schizophrenia, associated with physical, emotional, and cognitive challenges. Despite their clinical importance, changes in the multiple dimensions of AVHs during treatment have rarely been examined, and subjective views thereof hav...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/j.pnpbp.2019.109671

    authors: Kim SH,Hwang SS,Jung HY,Kim Y,Ahn YM,Chung IW,Kim YS

    更新日期:2019-12-20 00:00:00

  • Converging translational evidence for the involvement of the serotonin 2A receptor gene in major depressive disorder.

    abstract::An association between serotonin 2A receptor (5-HT2AR), encoded by HTR2A gene, and major depressive disorder (MDD) has been suggested. Here, we combined preclinical and ecological clinical approaches to explore the impact of impaired 5-HT2AR-mediated transmission on MDD or anxio-depressive-like phenotype in mice. Htr2...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.pnpbp.2014.04.013

    authors: Petit AC,Quesseveur G,Gressier F,Colle R,David DJ,Gardier AM,Ferreri F,Lépine JP,Falissard B,Verstuyft C,Guiard BP,Corruble E

    更新日期:2014-10-03 00:00:00

  • Season of birth and schizophrenia: sex difference.

    abstract::1. A statistically significant increased risk of schizophrenia for individuals born in winter has been reported. The increase risk is of the order of 5-15 percent. The seasonal effect is more marked among females. This winter birth effect suggests some environmental agents, probably a neuropathogen one, acting on the ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章

    doi:10.1016/0278-5846(95)00307-x

    authors: Dassa D,Azorin JM,Ledoray V,Sambuc R,Giudicelli S

    更新日期:1996-02-01 00:00:00

  • Effects of antidepressants on uptake and receptor systems in the brain.

    abstract::Many antidepressant drugs inhibit the neuronal uptake of norepinephrine, serotonin, epinephrine and/or dopamine. Some newer antidepressant drugs are highly selective in their ability to inhibit the uptake of one or more of these monoamines. This uptake inhibition, which would be expected to increase the synaptic conce...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/0278-5846(85)90006-5

    authors: Fuller RW,Wong DT

    更新日期:1985-01-01 00:00:00

  • Glucocorticoids, genes and brain function.

    abstract::The identification of key genes in transcriptomic data constitutes a huge challenge. Our review of microarray reports revealed 88 genes whose transcription is consistently regulated by glucocorticoids (GCs), such as cortisol, corticosterone and dexamethasone, in the brain. Replicable transcriptomic data were combined ...

    journal_title:Progress in neuro-psychopharmacology & biological psychiatry

    pub_type: 杂志文章,评审

    doi:10.1016/j.pnpbp.2017.11.020

    authors: Juszczak GR,Stankiewicz AM

    更新日期:2018-03-02 00:00:00